These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36348090)

  • 1. MRI can accurately diagnose breast cancer during lactation.
    Nissan N; Massasa EEM; Bauer E; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Samoocha D; Yagil Y; Ziv-Baran T; Anaby D; Sklair-Levy M
    Eur Radiol; 2023 Apr; 33(4):2935-2944. PubMed ID: 36348090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement.
    Nissan N; Anaby D; Mahameed G; Bauer E; Moss Massasa EE; Menes T; Agassi R; Brodsky A; Grimm R; Nickel MD; Roccia E; Sklair-Levy M
    Eur Radiol; 2023 Nov; 33(11):8122-8131. PubMed ID: 37278853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps.
    Nissan N; Allweis T; Menes T; Brodsky A; Paluch-Shimon S; Haas I; Golan O; Miller Y; Barlev H; Carmon E; Brodsky M; Anaby D; Lawson P; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Konen E; Sklair-Levy M
    Eur Radiol; 2020 Feb; 30(2):767-777. PubMed ID: 31529255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of the Lactating Breast: Computer-Aided Diagnosis False Positive Rates and Background Parenchymal Enhancement Kinetic Features.
    Nissan N; Sorin V; Bauer E; Anaby D; Samoocha D; Yagil Y; Faermann R; Halshtok-Neiman O; Shalmon A; Gotlieb M; Sklair-Levy M
    Acad Radiol; 2022 Sep; 29(9):1332-1341. PubMed ID: 34857455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
    Taron J; Fleischer S; Preibsch H; Nikolaou K; Gruber I; Bahrs S
    Eur Radiol; 2019 Mar; 29(3):1187-1193. PubMed ID: 30229271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
    Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
    Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background parenchymal enhancement assessment: Inter- and intra-rater reliability across breast MRI sequences.
    Bignotti B; Calabrese M; Signori A; Tosto S; Valdora F; Tagliafico A; Durando M; Mariscotti G
    Eur J Radiol; 2019 May; 114():57-61. PubMed ID: 31005177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
    Kim SY; Cho N; Choi Y; Shin SU; Kim ES; Lee SH; Chang JM; Moon WK
    Korean J Radiol; 2020 May; 21(5):561-571. PubMed ID: 32323501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
    Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
    Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?
    Marzocca F; Moffa G; Landi VN; Panzironi G; Kirchin MA; Pediconi F; Galati F
    Acta Radiol; 2022 Sep; 63(9):1173-1179. PubMed ID: 34323589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.
    Tudorica LA; Oh KY; Roy N; Kettler MD; Chen Y; Hemmingson SL; Afzal A; Grinstead JW; Laub G; Li X; Huang W
    Magn Reson Imaging; 2012 Nov; 30(9):1257-67. PubMed ID: 22770687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
    Kuhl CK; Schrading S; Strobel K; Schild HH; Hilgers RD; Bieling HB
    J Clin Oncol; 2014 Aug; 32(22):2304-10. PubMed ID: 24958821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.
    Pinker K; Bogner W; Baltzer P; Trattnig S; Gruber S; Abeyakoon O; Bernathova M; Zaric O; Dubsky P; Bago-Horvath Z; Weber M; Leithner D; Helbich TH
    Eur Radiol; 2014 Apr; 24(4):913-20. PubMed ID: 24306425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement.
    Wang H; Gao L; Chen X; Wang SJ
    Quant Imaging Med Surg; 2023 Oct; 13(10):6384-6394. PubMed ID: 37869283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
    Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
    J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence.
    Wu S; Zuley ML; Berg WA; Kurland BF; Jankowitz RC; Sumkin JH; Gur D
    Sci Rep; 2017 May; 7(1):2115. PubMed ID: 28522877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized assessment of background parenchymal enhancement on breast dynamic contrast-enhanced-MRI including electronic lesion removal.
    Douglas L; Fuhrman J; Hu Q; Edwards A; Sheth D; Abe H; Giger M
    J Med Imaging (Bellingham); 2024 May; 11(3):034501. PubMed ID: 38737493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.